| Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition M Kool, DTW Jones, N Jäger, PA Northcott, TJ Pugh, V Hovestadt, ... Cancer cell 25 (3), 393-405, 2014 | 815 | 2014 |
| Medulloblastoma Can Be Initiated by Deletion of Patched in Lineage-Restricted Progenitors or Stem Cells ZJ Yang, T Ellis, SL Markant, TA Read, JD Kessler, M Bourboulas, ... Cancer cell 14 (2), 135-145, 2008 | 767 | 2008 |
| An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides T Saric, SC Chang, A Hattori, IA York, S Markant, KL Rock, M Tsujimoto, ... Nature immunology 3 (12), 1169, 2002 | 736 | 2002 |
| Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma TA Read, MP Fogarty, SL Markant, RE McLendon, Z Wei, DW Ellison, ... Cancer cell 15 (2), 135-147, 2009 | 446 | 2009 |
| Nrdp1‐mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis XB Qiu, SL Markant, J Yuan, AL Goldberg The EMBO journal 23 (4), 800-810, 2004 | 158 | 2004 |
| WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum Y Pei, SN Brun, SL Markant, W Lento, P Gibson, MM Taketo, M Giovannini, ... Development, dev. 050104, 2012 | 148 | 2012 |
| Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma SN Brun, SL Markant, LA Esparza, G Garcia, D Terry, JM Huang, ... Oncogene 34 (29), 3770, 2015 | 69 | 2015 |
| Targeting sonic hedgehog-associated medulloblastoma through inhibition of Aurora and Polo-like kinases SL Markant, LA Esparza, J Sun, K Barton, LM McCoig, GA Grant, ... Cancer research, canres. 4258.2012, 2013 | 64 | 2013 |
| Matching mice to malignancy: molecular subgroups and models of medulloblastoma J Lau, C Schmidt, SL Markant, MD Taylor, RJ Wechsler-Reya, WA Weiss Child's Nervous System 28 (4), 521-532, 2012 | 38 | 2012 |
| Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma BA Emmenegger, EI Hwang, C Moore, SL Markant, SN Brun, JW Dutton, ... Oncogene 32 (35), 4181, 2013 | 33 | 2013 |
| Personalized mice: modelling the molecular heterogeneity of medulloblastoma SL Markant, RJ Wechsler‐Reya Neuropathology and applied neurobiology 38 (3), 228-240, 2012 | 28 | 2012 |
| The cellular origin of patched associated medulloblastomas Z Yang, T Ellis, S Markant, M Bourboulas, K McCue, TA Read, J Kessler, ... Neuro-Oncology 9 (4), 559-559, 2007 | 2 | 2007 |
| Cell Biology and Signaling PM Long, UV Wesley, DM Jaworski, M Rana, TR Kiehl, K So, P Gould, ... Neuro-Oncology 12 (suppl_4), iv7-iv25, 2010 | 1 | 2010 |
| Total survivin and acetylated survivin correlate with distinct molecular subtypes of breast cancer. HAM Shaaban, NH Hafez, HM Ragab, AI El Abadi, BW Stewart, CP Wild, ... International Journal of Cancer Research 12 (3-4), Pages: 630-Pages: 630, 2014 | | 2014 |
| NEURO/MEDICAL ONCOLOGY P Ambady, M Holdhoff, C Ferrigno, S Grossman, MD Anderson, D Liu, ... Neuro-Oncology 15 (suppl_3), iii98-iii135, 2013 | | 2013 |
| Genome Sequencing of SHH Medulloblastoma Predicts Age-Dependent Response to Smoothened-Inhibition and Rational Therapeutic Combinations M Kool, DTW Jones, N Jaeger, PA Northcott, T Pugh, V Hovestadt, ... NEURO-ONCOLOGY 15, 116-117, 2013 | | 2013 |
| 0041. Genome Sequencing Of Shh Medulloblastoma Predicts Age-dependent Response To Smoothened-inhibition And Rational Therapeutic Combinations M Kool, DT Jones, N Jaeger, PA Northcott, T Pugh, V Hovestadt, ... Neuro-oncology 15 (suppl_1), i1-i51, 2013 | | 2013 |
| Regulation of Cerebellar Development and Tumorigenesis by CXCR4 and by Aurora and Polo-Like Kinases SL Markant | | 2013 |
| Abstract CN07-02: Targeting tumor-initiating cells in medulloblastoma S Markant, LA Esparza, K Barton, J Sun, R Wechsler-Reya Cancer Prevention Research 5 (11 Supplement), CN07-02-CN07-02, 2012 | | 2012 |
| Abstract B46: Targeting tumor-propagating cells in medulloblastoma through inhibition of G2/M cell cycle regulators S Markant, LA Esparza, K Barton, J Sun, R Wechsler-Reya Clinical Cancer Research 18 (10 Supplement), B46-B46, 2012 | | 2012 |
